Carboxymethyl cellulose
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rabin Bista, M.B.B.S. [2]
Disclaimer
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
NOTE: Most over the counter (OTC) are not reviewed and approved by the FDA. However, they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Overview
Carboxymethyl cellulose is a Ophthalmologic Agent that is FDA approved for the treatment of burning, irritation and discomfort due to dryness of the eye. Common adverse reactions include eye pain, changes in vision, irritation of the eye.
Adult Indications and Dosage
FDA-Labeled Indications and Dosage (Adult)
Indications
- For the temporary relief of burning, irritation and discomfort due to dryness of the eye or exposure to wind or sun.
- May be used as a protectant against further irritation.
Directions
- To open, TWIST AND PULL TAB TO REMOVE. Instill 1 or 2 drops in the affected eye(s) as needed and discard container.
- If used for post-operative (e.g. LASIK) dryness and discomfort, follow your eye doctor’s instructions.
Off-Label Use and Dosage (Adult)
Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Carboxymethyl cellulose in adult patients.
Non–Guideline-Supported Use
There is limited information regarding Off-Label Non–Guideline-Supported Use of Carboxymethyl cellulose in adult patients.
Pediatric Indications and Dosage
FDA-Labeled Indications and Dosage (Pediatric)
There is limited information regarding FDA-Labeled Use of Carboxymethyl cellulose in pediatric patients.
Off-Label Use and Dosage (Pediatric)
Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Carboxymethyl cellulose in pediatric patients.
Non–Guideline-Supported Use
There is limited information regarding Off-Label Non–Guideline-Supported Use of Carboxymethyl cellulose in pediatric patients.
Contraindications
There is limited information regarding Carboxymethyl cellulose Contraindications in the drug label.
Warnings
- For external use only.
- To avoid contamination, do not touch tip of container to any surface. Do not reuse. Once opened, discard.
- Do not touch unit-dose tip to eye.
- Do not use if solution changes color or becomes cloudy.
- STOP USE AND ASK A DOCTOR
- If you experience eye pain, changes in vision, continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours.
- KEEP OUT OF REACH OF CHILDREN
- If swallowed, get medical help or contact a Poison Control Center right away.
Adverse Reactions
Clinical Trials Experience
Postmarketing Experience
There is limited information regarding Postmarketing Experience of Carboxymethyl cellulose in the drug label.
Drug Interactions
There is limited information regarding Carboxymethyl cellulose Drug Interactions in the drug label.
Use in Specific Populations
Pregnancy
- Pregnancy Category
- Australian Drug Evaluation Committee (ADEC) Pregnancy Category
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Carboxymethyl cellulose in women who are pregnant.
Labor and Delivery
There is no FDA guidance on use of Carboxymethyl cellulose during labor and delivery.
Nursing Mothers
There is no FDA guidance on the use of Carboxymethyl cellulose with respect to nursing mothers.
Pediatric Use
There is no FDA guidance on the use of Carboxymethyl cellulose with respect to pediatric patients.
Geriatic Use
There is no FDA guidance on the use of Carboxymethyl cellulose with respect to geriatric patients.
Gender
There is no FDA guidance on the use of Carboxymethyl cellulose with respect to specific gender populations.
Race
There is no FDA guidance on the use of Carboxymethyl cellulose with respect to specific racial populations.
Renal Impairment
There is no FDA guidance on the use of Carboxymethyl cellulose in patients with renal impairment.
Hepatic Impairment
There is no FDA guidance on the use of Carboxymethyl cellulose in patients with hepatic impairment.
Females of Reproductive Potential and Males
There is no FDA guidance on the use of Carboxymethyl cellulose in women of reproductive potentials and males.
Immunocompromised Patients
There is no FDA guidance one the use of Carboxymethyl cellulose in patients who are immunocompromised.
Administration and Monitoring
Administration
Monitoring
There is limited information regarding Monitoring of Carboxymethyl cellulose in the drug label.
IV Compatibility
There is limited information regarding IV Compatibility of Carboxymethyl cellulose in the drug label.
Overdosage
There is limited information regarding Overdose of Carboxymethyl cellulose in the drug label.
Pharmacology
This image is provided by the Wikipedia.
Mechanism of Action
There is limited information regarding Carboxymethyl cellulose Mechanism of Action in the drug label.
Structure
- ACTIVE INGREDIENT
- Carboxymethylcellulose sodium (CMC) 0.5% ............... Eye lubricant
- INACTIVE INGREDIENTS
- Calcium chloride; magnesium chloride; potassium chloride; purified water; sodium chloride; and sodium lactate. May also contain hydrochloric acid and/or sodium hydroxide to adjust pH.
Pharmacodynamics
There is limited information regarding Pharmacodynamics of Carboxymethyl cellulose in the drug label.
Pharmacokinetics
There is limited information regarding Pharmacokinetics of Carboxymethyl cellulose in the drug label.
Nonclinical Toxicology
There is limited information regarding Nonclinical Toxicology of Carboxymethyl cellulose in the drug label.
Clinical Studies
There is limited information regarding Clinical Studies of Carboxymethyl cellulose in the drug label.
How Supplied
Storage
There is limited information regarding Carboxymethyl cellulose Storage in the drug label.
Images
Drug Images
{{#ask: Page Name::Carboxymethyl cellulose |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}
Package and Label Display Panel
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL- 30 STERILE SINGLE USE CONTAINERS
This image is provided by the National Library of Medicine.
Ingredients and Appearance
This image is provided by the National Library of Medicine.
{{#ask: Label Page::Carboxymethyl cellulose |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}
Patient Counseling Information
There is limited information regarding Patient Counseling Information of Carboxymethyl cellulose in the drug label.
Precautions with Alcohol
- Alcohol-Carboxymethyl cellulose interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
Brand Names
- CARBOXYMETHYLCELLULOSE SODIUM®[1]
Look-Alike Drug Names
There is limited information regarding Carboxymethyl cellulose Look-Alike Drug Names in the drug label.
Drug Shortage Status
Price
References
The contents of this FDA label are provided by the National Library of Medicine.